Skip to content
Group parent company RE-tail Return Partners II0720.913.007

RE-tail Return Partners II

ActiveMerchtem, parent founded in 2019BODE I BV, BODE II BV and Veen NL BV
11
companies
in 2 countries
Staff in Belgium 0 FTE 1 company, 2025
Parent's equity€10.9mown accounts 2025

Insights on RE-tail Return Partners II

In 2019 the group counted 8 companies in 2 countries; in 2025 it counts 11 in 2 countries.

BODE I BV is the heaviest branch: RE-tail Return Partners II holds 100% of it, according to the 2025 list.

The sum of staff peaks in 2019 at 0 full-time equivalents.

The largest equity is not in Belgium: BODE I BV (€6.4m) and BODE II BV (€4.7m) stand above all Belgian subsidiaries.

Sources: the lists of holdings in the annual accounts of the group's companies (1 in 2025), their own annual accounts, the establishment units in the KBO and the ECB rates.
Equity
FTE
Standalone accounts

Events in the group

These are the publications about all Belgian group companies, such as bankruptcies, director changes and capital changes. Deeds are listed since January 2026, judgments from earlier years too.

1
  1. Capital decrease
    Capital changeRE-tail Return Partners IICapital from €17,195,645 to €8,189,056, 9,006,589 shares cancelled · Capital from €8,189,056 to €4,189,055, 4,000,001 shares cancelled

Permits and Peppol

Applications in Flanders
2
by 1 company, since 2021
2 granted
Peppol Directory
5 of 5
Belgian companies listed

Per company

Latest applications

  • Bouwen of herbouwen; Nieuwbouw of aanleggen; Nieuwbouw van bijgebouwen en niet overdekte lage constructie; Verbouwen en/of uitbreiden zonder functiewijziging en zonder wijziging van aantal woongelegenheden
    Granted on 22-08-2022submitted 21-02-2022IBBRauthority: Breeproject 2022025481
  • Verbouwen en/of uitbreiden zonder functiewijziging en met wijzigen van aantal woongelegenheden
    Granted on 23-05-2022submitted 20-12-2021IBBRauthority: Breeproject 2021193057

Source: Omgevingsloket Vlaanderen, applications in Flanders only; Peppol Directory.

Your exposure to this group